NCC-CDS2-C1

$600$1,500

Description

Cell line name NCC-CDS2-C1
Accession CVCL_YL70
Resource Identification Initiative To cite this cell line use: NCC-CDS2-C1 (RRID:CVCL_YL70)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~28 hours (PubMed=31898195).
Sequence variations
Gene fusion; HGNC; 14214; CIC + HGNC; 50800; DUX4; Name(s)=CIC-DUX4 (PubMed=31898195).
Disease CIC-DUX4 sarcoma (NCIt: C165663)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 50Y
Category Cancer cell line
STR profile

Source(s): PubMed=31898195

Markers:

Amelogenin X
CSF1PO 10
D5S818 8,11
D7S820 8,9
D13S317 8,11
D16S539 9,11
D21S11 29,30
TH01 7,9
TPOX 8,9
vWA 14,17

Publications
PubMed=31898195; DOI=10.1007/s13577-019-00312-x
Yoshimatsu Y., Noguchi R., Tsuchiya R., Kito F., Sei A., Sugaya J., Nakagawa M., Yoshida A., Iwata S., Kawai A., Kondo T.
Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
Hum. Cell 33:427-436(2020)

Cross-references
Encyclopedic resources Wikidata; Q95992508

Additional information

Weight N/A
ユーザー種別

Academia/non-profit organization, For-profit organization

Reviews

There are no reviews yet.

Be the first to review “NCC-CDS2-C1”

Your email address will not be published. Required fields are marked *

CAPTCHA